It has a similar effect to IL-17A, promoting the invasion and metastasis of pancreatic cancer and predicting both the prognosis of pancreatic cancer and the efficacy of gemcitabine treatment [18]. This evidence concerns the gene IL17A and familial pancreatic carcinoma.